Barry Zeluff

678 total citations
21 papers, 509 citations indexed

About

Barry Zeluff is a scholar working on Epidemiology, Surgery and Infectious Diseases. According to data from OpenAlex, Barry Zeluff has authored 21 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Surgery and 8 papers in Infectious Diseases. Recurrent topics in Barry Zeluff's work include Transplantation: Methods and Outcomes (6 papers), Cytomegalovirus and herpesvirus research (5 papers) and Antifungal resistance and susceptibility (4 papers). Barry Zeluff is often cited by papers focused on Transplantation: Methods and Outcomes (6 papers), Cytomegalovirus and herpesvirus research (5 papers) and Antifungal resistance and susceptibility (4 papers). Barry Zeluff collaborates with scholars based in United States, South Africa and Malaysia. Barry Zeluff's co-authors include Layne O. Gentry, Saima Aslam, Michael J. Keating, Rabih O. Darouiche, Victor Fainstein, Maria Hernandez, Lawrence S. Frankel, Kapil Mehta, Gerald P. Bodey and John Thornby and has published in prestigious journals such as New England Journal of Medicine, Circulation and Clinical Infectious Diseases.

In The Last Decade

Barry Zeluff

21 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barry Zeluff United States	11	234	178	152	90	50	21	509
Grace Y. Minamoto United States	11	286 1.2×	229 1.3×	95 0.6×	53 0.6×	27 0.5×	20	528
José Elías García‐Sánchez Spain	12	211 0.9×	102 0.6×	109 0.7×	16 0.2×	92 1.8×	40	556
Jimmy Chua United States	10	373 1.6×	198 1.1×	191 1.3×	36 0.4×	42 0.8×	14	847
Eric Neibart United States	11	172 0.7×	186 1.0×	122 0.8×	16 0.2×	24 0.5×	14	390
Anne‐Claude Crémieux France	13	199 0.9×	188 1.1×	355 2.3×	19 0.2×	53 1.1×	30	597
Catharina F. M. Linssen Netherlands	13	351 1.5×	161 0.9×	44 0.3×	23 0.3×	33 0.7×	35	599
Suzan Saçar Türkiye	14	169 0.7×	170 1.0×	129 0.8×	15 0.2×	79 1.6×	41	566
Waheed N. Khan United States	16	472 2.0×	92 0.5×	79 0.5×	32 0.4×	97 1.9×	32	902
Christine Koval United States	18	283 1.2×	363 2.0×	328 2.2×	220 2.4×	40 0.8×	47	872
Anna Maria Azzini Italy	17	225 1.0×	238 1.3×	93 0.6×	20 0.2×	24 0.5×	46	576

Countries citing papers authored by Barry Zeluff

Since Specialization

Citations

This map shows the geographic impact of Barry Zeluff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Zeluff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Zeluff more than expected).

Fields of papers citing papers by Barry Zeluff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Zeluff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Zeluff. The network helps show where Barry Zeluff may publish in the future.

Co-authorship network of co-authors of Barry Zeluff

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Zeluff. A scholar is included among the top collaborators of Barry Zeluff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Zeluff. Barry Zeluff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Farmakiotis, Dimitrios & Barry Zeluff. (2016). Metronidazole-Associated Encephalopathy. New England Journal of Medicine. 374(15). 1465–1465. 16 indexed citations

Aslam, Saima, Maria Hernandez, John Thornby, Barry Zeluff, & Rabih O. Darouiche. (2010). Risk Factors and Outcomes of Fungal Ventricular‐Assist Device Infections. Clinical Infectious Diseases. 50(5). 664–671. 79 indexed citations

Aslam, Saima, Maria Hernandez, John Thornby, Barry Zeluff, & Rabih O. Darouiche. (2010). Reply to Ensor et al. Clinical Infectious Diseases. 51(5). 633–634. 1 indexed citations

Hernandez, Maria, Mohammad D. Mansouri, Saima Aslam, Barry Zeluff, & Rabih O. Darouiche. (2008). Efficacy of Combination of N-acetylcysteine, Gentamicin, and Amphotericin B for Prevention of Microbial Colonization of Ventricular Assist Devices. Infection Control and Hospital Epidemiology. 30(2). 190–192. 13 indexed citations

López, J. Antonio G., et al.. (1995). Successful thrombolysis for prosthetic pulmonary valve obstruction.. PubMed. 22(2). 197–9. 6 indexed citations

Gentry, Layne O., Barry Zeluff, & Marcia A. Kielhofner. (1994). DERMATOLOGIC MANIFESTATIONS OF INFECTIOUS DISEASES IN CARDIAC TRANSPLANT PATIENTS. Infectious Disease Clinics of North America. 8(3). 637–654. 10 indexed citations

Massin, Edward K., Barry Zeluff, Branislav Radovančević, et al.. (1994). Cardiac transplantation and aspergillosis.. Circulation. 90(3). 1552–1556. 3 indexed citations

Zeluff, Barry, et al.. (1992). Frequency and significance of infections in patients receiving prolonged LVAD support.. PubMed. 37(3). M283–5. 24 indexed citations

Duncan, J. Michael, et al.. (1992). Leishmaniasis in a heart transplant patient.. PubMed. 11(4 Pt 1). 820–3. 37 indexed citations

10.

Steingrube, V A, Richard J. Wallace, Barbara A. Brown, et al.. (1991). Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid. Antimicrobial Agents and Chemotherapy. 35(3). 524–528. 26 indexed citations

11.

Bodey, Gerald P., Victor Fainstein, Michael J. Keating, et al.. (1989). Treatment of systemic fungal infections with liposomal amphotericin B.. PubMed. 149(11). 2533–6. 151 indexed citations

12.

Gentry, Layne O. & Barry Zeluff. (1988). Nosocomial and other difficult infections in the immunocompromised cardiac transplant patient. Journal of Hospital Infection. 11. 21–28. 10 indexed citations

13.

Zeluff, Barry, et al.. (1988). Evaluation of roxithromycin (RU-965) versus cephradine in pneumococcal pneumonia. European Journal of Clinical Microbiology & Infectious Diseases. 7(1). 69–71. 8 indexed citations

14.

Gentry, Layne O., Barry Zeluff, & Denton A. Cooley. (1988). Antibiotic Prophylaxis in Open-Heart Surgery: A Comparison of Cefamandole, Cefuroxime, and Cefazolin. The Annals of Thoracic Surgery. 46(2). 167–171. 36 indexed citations

15.

Keay, Susan, Eskild Petersen, Timothy B. Icenogle, et al.. (1988). Ganciclovir Treatment of Serious Cytomegalovirus Infection in Heart and Heart-Lung Transplant Recipients. Clinical Infectious Diseases. 10(Supplement_3). S563–S572. 43 indexed citations

16.

Zeluff, Barry & Layne O. Gentry. (1987). Management of infection in the post-cardiac-transplant patient.. PubMed. 14(3). 247–51. 1 indexed citations

17.

Zeluff, Barry & Layne O. Gentry. (1987). Cefamandole prophylaxis for cardiovascular surgery: a dosage comparison.. PubMed. 14(4). 374–81. 3 indexed citations

18.

Gentry, Layne O. & Barry Zeluff. (1986). Diagnosis and Treatment of Infection in Cardiac Transplant Patients. Surgical Clinics of North America. 66(3). 459–465. 19 indexed citations

19.

Zeluff, Barry, et al.. (1986). Cefadroxil Compared with Cefaclor in the Treatment of Streptococcal Pneumonia in Adults. Drugs. 32(Supplement 3). 39–42. 6 indexed citations

20.

Reece, I J, et al.. (1984). Infection after cardiac transplantation: treatment and prognosis.. PubMed. 11(1). 32–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact